Study of Gemcitabine Plus Nab-paclitaxel Versus S1 Plus Nab-paclitaxel in Metastatic Adenocarcinoma of the Pancreas

Clinical trial NCT03779464 · UNKNOWN

Trial details

NCT number: NCT03779464
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Cancer Nab-paclitaxel Gemcitabine S1

Start date: 2019-08-01
Primary completion: 2020-12-30
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.